The Trial Data That Was Quietly Adjusted

SITE-07 reports the lowest adverse-event rate of any trial site. But 9 of its patients were "withdrawn" just 1-3 days before their scheduled follow-up visit — the exact visit where an adverse event would most likely surface. SITE-03 also has a low rate, but its patient population is documented as younger and healthier, and its withdrawals aren't clustered before follow-ups at all.